Skip to main content

This job has expired

Clinical Development Leader for Immuno-Oncology

Employer
Bayer U.S.
Location
Whippany, New Jersey
Salary
Full Benefits & Bonus
Closing date
Jun 30, 2019

View more

Job Details

The primary responsibilities of this role, Clinical Development Leader for Immuno-Oncology, are to: 

  • serve as the lead for the early clinical team and be responsible for the exploratory clinical development of drug candidates until transition to late stage development, driving the design, execution and delivery of the early clinical development plan in collaboration with other cross-functional team members;
  • be responsible for the medical/safety aspects and risk-benefit assessments;
  • assesses and ensures validity of efficacy data;
  • review and interprets medical data to identify possible patient safety and data integrity issues;
  • leads and manages relationships with key internal/external stakeholders;
  • trains internal/external stakeholders and performs the protocol review during the site initiation visit and may be representing the team to other decision/governance meetings, senior management or advisory boards as applicable.

 

Who you are

 

Your success will be driven by your demonstration of our LIFE values.  More specifically related to this position, Bayer seeks an incumbent who possesses the following:

  •  MD degree (or foreign equivalent) plus four (4) years of clinical practice experience in either oncology or immunology with clinical research experience; 
  •  four (4) years of experience in oncology clinical drug development;
  •  exploratory early clinical drug development specific to Oncology; 
  • the complexities of and recent developments in Oncology;
  • global clinical research, basic biostatistics, safety reporting, and working with/within GCP;
  • writing clinical research protocols, informed consent documents, and communications with clinical investigators;
  • training study teams, monitors, site staff and CRO staff (if applicable) on medical aspects of the study, indication and compound;
  • developing Clinical Study Protocols and acting as a medical monitor for clinical research trials;
  • electronic medical review tool systems;
  • reviewing, preparing and delivering live safety data presentations for internal and external committees;
  • discussing and presenting the scientific/mechanistic aspects of drug development; and
  • the relevant regulatory and legal environment.

 

Must be able and willing to travel domestically and internationally to attend both internal and external business meetings and workshops several times per year.

Experience can be concurrent.

 

YOUR APPLICATION     

Bayer offers a wide variety of competitive compensation and benefits programs. If you meet the requirements of this unique opportunity, and you have the "Passion to Innovate" and the "Power to Change", we encourage you to apply now. To all recruitment agencies: Bayer does not accept unsolicited third party resumes.

Bayer is an Equal Opportunity Employer/Disabled/Veterans

    

Bayer is committed to providing access and reasonable accommodations in its application process for individuals with disabilities and encourages applicants with disabilities to request any needed accommodation(s) using the contact information below.    

       

Location: United States : New Jersey : Whippany     

Division: Pharmaceuticals    

Reference Code: 42102

Contact Us  

+ 1 888-473-1001, option #5

Company

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At Bayer you have the opportunity to be part of a culture where we value the passion of our employees to innovate and give them the power to change.

The Oncology Strategic Business Unit within the Pharmaceuticals Division of Bayer integrates key strategic and select operations functions from Drug Discovery, Development, Medical Affairs, and Strategic Marketing including Market Access.

The Strategic Business Unit enables the company to strategically manage and deliver upon it’s growing oncology portfolio, as well as its early –and late-stage development candidates, with a focused and integrated approach in a highly competitive and rapidly evolving environment.  The unit’s operating model will especially support accelerated development of potential therapeutic options for patients to fight cancer.

Company info
Website

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert